Submission — Abstract submission has now closed
Abstract submission closed on 8/3/2022 at midnight. We thank all authors for submitting their work for the various scientific tracks.
Notifications on the outcome of the abstract review process will be sent out on 29/03/2022.
|Medical||This includes both clinical and preclinical abstracts|
|Young Nuclearist Challenge||A longstanding tradition, this category focuses on case reports highlighting interesting clinical cases where nuclear medicine played a substantial role|
|Technologist||Abstracts by and for technologists|
|Radiochemistry and Radiopharmacy||Focuses on developments in radio-labeling strategies and on new radiopharmaceutical development|
|Physics and Engineering||New developments in nuclear instrumentation, algorithms, software and calibration|
The best abstract in each category as determined by the scientific program committee will receive a prize during the BELNUC award ceremony.
Submitted abstracts need to confirm with the following requirements:
- Abstracts should be structured using the Aim/Methods/Results/Conclusion headings, except submissions for the Young Nuclearist Challenge, which should consist of a Case Presentation and Discussion section
- Maximum of 400 words
- Maximum 1 figure/table
By submitting an abstract, you agree to the BELNUC abstract policy and recognize that all decisions made by the scientific committee are final.
All abstracts must be submitted using the BELNUC abstract submission system. Submissions by email cannot be accepted.